Sponsors

Evolutionary Diversity as a Source for Anticancer Molecules

A new textbook entitled Evolutionary Diversity as a Source for Anticancer Molecules discusses evolutionary diversity as a source for anticancer agents derived from bacteria, algae, bryophytes, pteridophytes, and gymnosperms.

The book goes over the isolation of anticancer agents and the technology-enabled screening process used to develop anticancer drugs. The book also includes discussion of the nutraceuticals and natural products derived from invertebrates that can be used as part of cancer treatment.

Evolutionary Diversity as a Source for Anticancer Molecules (ISBM 978-0-12-821710-8) also deals with some of the current challenges in the prevention of cancer as well as the side effects of conventional drugs used for cancer patients.

This book is a valuable resource for cancer researchers, oncologists, biotechnologists, pharmacologists, and any member of the biomedical field interested in understanding more about natural products with anticancer potential.

Latest Issues

DIA-MHRA Global Summit

Senate House, Malet Street, London, WC1E 7HU
16-17 November, 2026

UK NEQAS for Microbiology & Parasitology Annual Scientific Meeting 2026

The Royal National Hotel, 38 – 51 Bedford Way, London, WC1H 0DG
27 November, 2026

UK NEQAS webinar: Epigenetics

Online
1 December, 2026

Weqas Annual POCT Conference 2026

London, Venue - TBC
8-9 December, 2026

UK NEQAS webinar: Fresh Muscle Biopsies

Online
8 December, 2026